Impact of metformin on neocortical development during pregnancy: Involvement of ERK and p35/CDK5 pathways
Chemosphere · 2024-06 · 358 · 142124
DOI: 10.1016/j.chemosphere.2024.142124 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemosphere, 2024-06. Verfasst von Muhammet Oner und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Sciences, National Chung Hsing University, Taichung, 40227, Taiwan. Hauptthemen laut MEDLINE: Metformin, Neocortex, Cyclin-Dependent Kinase 5, Cell Proliferation. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 72 Literaturangaben. Gefördert von: Tungs' Taichung MetroHarbor Hospital, National Science and Technology Council, National Chung-Hsing University.
Abstract (Originalsprache)
Metformin, the most commonly prescribed drug for the treatment of diabetes, is increasingly used during pregnancy to address various disorders such as diabetes, obesity, preeclampsia, and metabolic diseases. However, its impact on neocortex development remains unclear. Here, we investigated the direct effects of metformin on neocortex development, focusing on ERK and p35/CDK5 regulation. Using a pregnant rat model, we found that metformin treatment during pregnancy induces small for gestational age (SGA) and reduces relative cortical thickness in embryos and neonates. Additionally, we discovered that metformin inhibits neural progenitor cell proliferation in the sub-ventricular zone (SVZ)/ventricular zone (VZ) of the developing neocortex, a process possibly mediated by ERK inactivation. Furthermore, metformin induces neuronal apoptosis in the SVZ/VZ area of the developing neocortex. Moreover, metformin retards neuronal migration, cortical lamination, and differentiation, potentially through p35/CDK5 inhibition in the developing neocortex. Remarkably, compensating for p35 through in utero electroporation partially rescues metformin-impaired neuronal migration and development. In summary, our study reveals that metformin disrupts neocortex development by inhibiting neuronal progenitor proliferation, neuronal migration, cortical layering, and cortical neuron maturation, likely via ERK and p35/CDK5 inhibition. Consequently, our findings advocate for caution in metformin usage during pregnancy, given its potential adverse effects on fetal brain development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Life Sciences, National Chung Hsing University, Taichung, 40227, Taiwan.
- Translational Cell Therapy Center, Department of Medical Research, China Medical University Hospital, Taichung, 40447, Taiwan.
- Department of Animal Science, National Chung Hsing University, Taichung, 40227, Taiwan.
- Department of Life Sciences, National Chung Hsing University, Taichung, 40227, Taiwan. Electronic address: hlin@dragon.nchu.edu.tw.
Förderung
- Tungs' Taichung MetroHarbor Hospital
- National Science and Technology Council
- National Chung-Hsing University
- Kaohsiung Veterans General Hospital
- Taichung Veterans General Hospital
Zitieren
APA
Oner, M., Chen, M. C., Cheng, P. T., Li, Y. H., Cheng, Y. C., Celik, A., Soong, S. W., Hsu, L. W., Lin, D. Y., Hossain Prince, G. M. S., Dhar, T., Cheng, H. C., Tang, P. C., & Lin, H. (2024). Impact of metformin on neocortical development during pregnancy: Involvement of ERK and p35/CDK5 pathways. Chemosphere, 358, 142124. https://doi.org/10.1016/j.chemosphere.2024.142124
Vancouver
Oner M, Chen MC, Cheng PT, Li YH, Cheng YC, Celik A, et al. Impact of metformin on neocortical development during pregnancy: Involvement of ERK and p35/CDK5 pathways. Chemosphere. 2024;358:142124. doi:10.1016/j.chemosphere.2024.142124
BibTeX
@article{Oner2024,
author = {Oner, Muhammet and Chen, Mei-Chih and Cheng, Pang-Ting and Li, Yu-Hsuan and Cheng, Yu-Chiao and Celik, Ayse and Soong, Shiuan-Woei and Hsu, Li-Wen and Lin, Din-You and Hossain Prince, G M Shazzad and Dhar, Trayee and Cheng, Hsu-Chen and Tang, Pin-Chi and Lin, Ho},
title = {Impact of metformin on neocortical development during pregnancy: Involvement of ERK and p35/CDK5 pathways},
journal = {Chemosphere},
year = {2024},
volume = {358},
pages = {142124},
doi = {10.1016/j.chemosphere.2024.142124}
}
EUVIMED